Page last updated: 2024-08-17

medroxyprogesterone acetate and Hyperprolactinemia

medroxyprogesterone acetate has been researched along with Hyperprolactinemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Erdenebaatar, C; Honda, R; Katabuchi, H; Monsur, M; Ohba, T; Saito, F; Tashiro, H; Yamaguchi, M	1
Hata, T; Matsumoto, J	1
Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M	1

Trials

1 trial(s) available for medroxyprogesterone acetate and Hyperprolactinemia

Article	Year
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer. Onkologie, 1986, Volume: 9, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine	1986

Article

Year

Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.

Onkologie, 1986, Volume: 9, Issue:6

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine

1986

Other Studies

2 other study(ies) available for medroxyprogesterone acetate and Hyperprolactinemia

Article	Year
Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:3 Topics: Adult; Antineoplastic Agents, Hormonal; Cabergoline; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hyperprolactinemia; Lectins, C-Type; Medroxyprogesterone Acetate; Retrospective Studies; Young Adult	2018
Re-evaluation of secondary amenorrheic patients one year after initial diagnosis: a prospective study. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2004, Volume: 71, Issue:1 Topics: Adolescent; Adult; Amenorrhea; Anovulation; Contraceptives, Oral; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hyperprolactinemia; Hypogonadism; Medroxyprogesterone Acetate; Prospective Studies; Time Factors	2004

Article

Year

Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:3

Topics: Adult; Antineoplastic Agents, Hormonal; Cabergoline; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hyperprolactinemia; Lectins, C-Type; Medroxyprogesterone Acetate; Retrospective Studies; Young Adult

2018

Re-evaluation of secondary amenorrheic patients one year after initial diagnosis: a prospective study.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2004, Volume: 71, Issue:1

Topics: Adolescent; Adult; Amenorrhea; Anovulation; Contraceptives, Oral; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hyperprolactinemia; Hypogonadism; Medroxyprogesterone Acetate; Prospective Studies; Time Factors

2004